06-953
Anti-phospho-FKHRL1 (Ser253) Antibody
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Quality Level
antibody product type
primary antibodies
Still not finding the right product?
Try our Product Selector Tool to narrow your options
Storage Class
10-13 - German Storage Class 10 to 13
Regulatory Information
新产品
This item has
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Deregulation of FOXO3A during prostate cancer progression.
Sanjeev Shukla,Meenakshi Shukla,Gregory T Maclennan,Pingfu Fu,Sanjay Gupta
International journal of oncology null
Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-Jun NH2-terminal kinase and Akt.
Sunters, A; Madureira, PA; Pomeranz, KM; Aubert, M; Brosens, JJ; Cook, SJ; Burgering et al.
Cancer Research null
Stephen E McGowan et al.
Respiratory research, 14, 68-68 (2013-07-04)
Secondary pulmonary alveolar septal formation requires platelet derived growth factor (PDGF-A) and platelet derived growth factor receptor-alpha (PDGFRα), and their regulation influences alveolar septal areal density and thickness. Insufficient PDGFRα expression in lung fibroblasts (LF) results in failed septation. Mice